Texas Capital Bancshares, Inc.
NASDAQ: TCBIO · FINANCIAL SERVICES · BANKS - REGIONAL
Updated 2026-11-06
Texas Capital Bancshares, Inc. (TCBIO) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $138.74M | $28.92M | 100.00% | 117.93% | 20.85% |
| 2007 | $160.38M | $29.42M | 100.00% | 121.83% | 18.35% |
| 2008 | $174.21M | $24.27M | 100.00% | 77.14% | 13.93% |
| 2009 | $225.95M | $24.15M | 100.00% | 36.79% | 10.69% |
| 2010 | $273.94M | $37.19M | 100.00% | 34.66% | 13.58% |
| 2011 | $335.17M | $75.98M | 100.00% | 40.88% | 22.67% |
| 2012 | $408.42M | $120.67M | 100.00% | 29.56% | 29.55% |
| 2013 | $444.54M | $121.05M | 100.00% | 27.23% | 27.23% |
| 2014 | $497.48M | $136.35M | 100.00% | 37.75% | 27.41% |
| 2015 | $551.02M | $144.85M | 100.00% | 35.98% | 26.29% |
| 2016 | $623.59M | $155.12M | 100.00% | 33.62% | 24.87% |
| 2017 | $791.58M | $197.06M | 100.00% | 36.39% | 24.89% |
| 2018 | $905.88M | $300.82M | 100.00% | 40.14% | 33.21% |
| 2019 | $1.05B | $322.87M | 100.00% | 38.79% | 30.76% |
| 2020 | $989.72M | $66.29M | 100.00% | 9.29% | 6.70% |
| 2021 | $879.30M | $253.94M | 100.00% | 38.45% | 28.88% |
| 2022 | $1.16B | $332.48M | 100.00% | 31.85% | 28.68% |
| 2023 | $1.00B | $189.14M | 100.00% | 24.57% | 18.85% |
| 2024 | $1.76B | $77.51M | 49.15% | 16.28% | 4.40% |
| 2025 | $2.00B | $330.24M | 60.07% | 21.65% | 16.52% |
Frequently asked questions
What is Texas Capital Bancshares, Inc.'s revenue?
Texas Capital Bancshares, Inc.'s trailing twelve-month revenue is $1.27B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is TCBIO?
In its most recent fiscal year, TCBIO ran a gross margin of 60.07%, an operating margin of 21.65%, and a net margin of 16.52%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does TCBIO generate?
TCBIO produced $347.58M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is TCBIO's balance sheet healthy?
TCBIO holds $201.31M in cash and equivalents against $620.58M in long-term debt, on $3.63B of shareholder equity. That debt is best read against the cash flow the business throws off each year.